ClinicalTrials.Veeva

Menu

Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure

U

University Hospital, Saarland

Status

Completed

Conditions

Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT01429857
Hom-AHF-Troponin

Details and patient eligibility

About

The purpose of this study is to investigate the prognostic value of admission high-sensitivity troponin in patients with acute decompensated heart failure.

Full description

Patients admitted for acute decompensated heart failure are included in the study. After gaining informed consent, concentrations of high-sensitivity troponin on admission and on discharge are assessed. 6 months after discharged, the incidence of clinical endpoint (mortality of all cause and of cardiovascular cause, hospitalization) is assessed by telephone contact to the patient and/or the physician. The aim of the study is to investigate the prognostic value of high-sensitivity troponin concentration for predicting death and re-hospitalization.

Enrollment

304 patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospital admission for acute cardiac decompensation
  • Systolic and / or diastolic heart failure

Exclusion criteria

  • Myocardial infarction in the last 4 weeks
  • Serum creatinine >2.5 mg/dl
  • Pulmonary embolism

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems